- AstraZeneca to Buy Alexion for $39 Billion in Cash and StockĀ Ā Bloomberg
- AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial DevelopmentĀ Ā Business Wire
- AstraZeneca to acquire Boston biotech Alexion, accelerating the companyās strategic and financial developmentĀ Ā The Boston Globe
- AstraZeneca Agrees to Buy Alexion for $39 BillionĀ Ā The Wall Street Journal
- AstraZeneca to buy Alexion in $39bn immunology dealĀ Ā Financial Times
- View Full Coverage on Google News
Top stories – Google News
